Ablation Study of a Fairness Auditing Agentic System for Bias Mitigation in Early-Onset Colorectal Cancer Detection
Organizations: Cedars-Sinai Medical Center, Los Angeles, CA, USA
Abstract
Artificial intelligence (AI) is increasingly used in clinical settings, yet limited oversight and domain expertise can allow algorithmic bias and safety risks to persist. This study evaluates whether an agentic AI system can support auditing biomedical machine learning models for fairness in early-onset colorectal cancer (EO-CRC), a condition with documented demographic disparities. We implemented a two-agent architecture consisting of a Domain Expert Agent that synthesizes literature on EO-CRC disparities and a Fairness Consultant Agent that recommends sensitive attributes and fairness metrics for model evaluation. An ablation study compared three Ollama large language models (8B, 20B, and 120B parameters) across three configurations: pretrained LLM-only, Agent without Retrieval-Augmented Generation (RAG), and Agent with RAG. Across models, the Agent with RAG achieved the highest semantic similarity to expert-derived reference statements, particularly for disparity identification, suggesting agentic systems with retrieval may help scale fairness auditing in clinical AI.
Figures & tables
| Ground Truth Agent 1 | Ground Truth Agent 2 |
| “Yes, there are well-documented disparities in early-onset colorectal cancer in both diagnosis and prognosis. Specifically, racial and ethnic minorities, particularly Black and Hispanic patients, and individuals from lower socioeconomic backgrounds are more likely to experience delayed diagnosis, present with more advanced disease, and have worse survival compared with non-Hispanic White patients. Men with early-onset colorectal cancer also have poorer survival outcomes than women. These disparities are driven by differences in access to care, delays in symptom evaluation and treatment, insurance and neighborhood socioeconomic factors, persistent inequities in stage at diagnosis and receipt of timely care, as well as emerging evidence of race- and ethnicity-associated genetic and epigenetic differences that may influence tumor behavior.” | “Given that the documented disparities lie in missed and delayed diagnoses, and worse survival among Black, Hispanic, lower-SES patients, and men, you should consider including equal opportunity, false negative rate parity, and equalized odds if feasible.” |
| Model | Agent | Condition | ||||
|---|---|---|---|---|---|---|
| Llama 3.1 8B | Agent 1 | LLM | 100 | 0.775 | 0.780 | 0.081 |
| Agent (NR) | 100 | 0.754 | 0.758 | 0.085 | ||
| Agent (R) | 100 | 0.802 | 0.812 | 0.041 | ||
| Agent 2 | LLM | 100 | 0.605 | 0.600 | 0.042 | |
| Agent (NR) | 100 | 0.596 | 0.597 | 0.034 | ||
| Agent (R) | 100 | 0.686 | 0.692 | 0.048 |
| Model | Agent | Overall test | Pairwise comparison ( Holm) |
|---|---|---|---|
| Llama 3.1 8B | Agent 1 | , | Agent (NR) LLM ( ) |
| Agent (R) LLM ( ) | |||
| Agent (R) Agent (NR) ( ) | |||
| Agent 2 | , | Agent (NR) LLM ( ) | |
| Agent (R) LLM ( ) | |||
| Agent (R) Agent (NR) ( ) |
Algorithmic Fairness
Algorithmic fairness studies how automated decisions distribute errors, opportunities, and harms across groups, and how to measure and reduce disparities.
See all 419 papers